Veterinary Vaccine Trends and Forecast
The future of the global veterinary vaccine market looks promising with opportunities in the veterinary hospital, veterinary clinic, and pharmacy & drug store markets. The global veterinary vaccine market is expected to reach an estimated $14.3 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are increasing number of zoonotic illnesses, growing customer demand for foods derived from animals, and rising initiatives from numerous governmental organizations and animal associations.
• Lucintel forecasts that, within the product category, live attenuated is expected to witness the highest growth over the forecast period.
• Within the distribution channel category, a veterinary clinic is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.
A more than 150-page report is developed to help in your business decisions.
Emerging Trends in the Veterinary Vaccine Market
Several trends are evolving in the market, such as the advancement of technology, changing consumer behavior, and the enhanced focus on animal welfare or the use of more high-tech pets. Some of the key areas of growth include mRNA technology, the adoption of digital health solutions including teleconsultation, novel vaccine formats, heightened preventive services, and increased collaboration in R&D, practices, and clinical research. Most importantly, these trends are changing the market structure for the better by increasing the efficacy and ease of access to vaccines.
• Emergence of mRNA Vaccines: The adoption of mRNA technologies in the veterinary vaccine market is transforming the control of diseases in animals. mRNA vaccines are considered to have better safety and the ability to target new infectious agents. Their ability to generate potent immune responses has drawn the attention of pharmaceutical companies to explore the market. With an increasing number of mRNA vaccines receiving marketing authorization, a surge in pet and livestock vaccination across the veterinary landscape is anticipated.
• Incorporation of Digital Technologies: The incorporation of digital technologies in the management of vaccines is transforming the veterinary vaccines industry. The use of digital platforms helps ensure adherence to vaccination regimens for pet owners and farmers by facilitating tracking of vaccination schedules. In addition, the applications of telemedicine are enhancing the interface between veterinarians and clients, allowing faster responses. In this way, vaccination procedures are expedited, and the understanding of their need is raised, thereby improving the health of animals.
• Introduction of Multivalent Vaccines: The introduction of multivalent vaccines is on the rise as more manufacturers seek to create vaccines that address multiple ailments with fewer needles. These vaccines are user-friendly, making it easier for pet owners and even farmers to follow vaccination protocols, lowering healthcare costs. With more multivalent vaccines flooding the market, the veterinary industry can expect an increase in pet vaccinations and better control of infectious diseases, leading to improved immunity for herds.
• Increasing Focus on Preventive Care: Emphasis on preventive health measures in the veterinary field is increasing the need for vaccines. Both pet owners and livestock farmers have come to appreciate the importance of vaccinations in animal and disease management. This is leading people and organizations to allocate more towards preventive health measures, which may include regular vaccinations. As the focus on proactive care increases, the veterinary vaccine market is set to grow, with advancements in new developments and improvements in animal healthcare.
• Growing Partnerships in Research and Development: Increasing collaboration between veterinary drug companies and research organizations is accelerating vaccine market growth. These collaborations aim to develop new vaccines or modify current ones for use in other indications that are entirely different from the original. These partnerships facilitate the reciprocal transfer of resources and knowledge, resulting in shorter time frames for developing better vaccines. As trends in medicine change and evolve, so will the veterinary vaccine market as it finds new ways to address changing health needs.
These emerging trends are reshaping the veterinary vaccine market by improving the effectiveness, availability, and results of vaccines. The emergence of new mRNA vaccines and new combination formulations assists in disease management, while technology aids in compliance and communication. Dedication to preventive care and collaboration through research programs ensures a global approach to animal health, driving steady market growth within the veterinary vaccine industry in the coming years.
Recent Developments in the Veterinary Vaccine Market
Recent trends in the veterinary vaccine market are self-advancing, involving innovations, collaborations, and adjustments to regulations. Some of the key trends include the presence of mRNA vaccines, the availability of combination vaccines, advancements in digital systems, research collaboration, and country-driven vaccination programs. The rapid adoption of these developments is growing, enhancing the health of animals, and most importantly, the use of veterinary vaccines in animal management will not fade away.
• Introduction of mRNA Vaccines: The introduction of mRNA vaccines marks an advancement in the development of veterinary vaccines. This technology expands the scope of veterinary vaccination by accommodating rapid changes to counter newly emerged diseases, while offering better safety than conventional vaccines. The development of the mRNA vaccine market for pets and livestock will lead to an increase in the use of this technology, improving disease management and reducing zoonotic outbreaks.
• Emergence of Combination Vaccines: The emergence of combination vaccines is changing the way vaccinations are done in veterinary practice. These vaccines save time and costs for pet owners and livestock farmers, as only one vaccine administration is required to prevent multiple diseases. This will help improve vaccination rates and disease control. With the approval of more combination vaccines entering the market, it is safe to say that the demand for veterinary vaccines will continue to increase.
• Upgraded Digital Engine Management Systems: Enhanced digital management systems for tracking and monitoring vaccines have started being adopted in the veterinary sphere. Such systems improve adherence to vaccination schedules and enhance interaction between veterinarians and clients. By using digital technologies, pet owners can track health records and ensure timely vaccinations. This development not only raises vaccination levels but also fosters a preventive mindset, which is more beneficial for the long-term health of animals.
• Vaccine Development Collaborations: Research collaborations involving veterinary pharmaceutical companies and academic institutes are contributing to the advancement of vaccines in the marketplace. These collaborations aim to create improved vaccines and modify current ones to offer more effective veterinary vaccines for preventing emerging diseases. These partnerships combine various methods and skills, accelerating the research and development process and making it possible to create new vaccines to address evolving veterinary health needs.
• Government-Supported Vaccination Programs: Government-supported vaccination programs are especially beneficial in providing veterinary vaccines to poorer regions of the world. These programs aim to encourage livestock vaccination to reduce disease and ensure food security. Governments are creating an environment that promotes animal health by providing facilities for vaccine health and distribution. This is likely to accelerate the need for veterinary vaccines, positively impacting the entire market.
These recent developments are changing the dynamics of the veterinary vaccine market by improving vaccination practices, compliance, and innovation. The development and adoption of mRNA and combination vaccines, along with stronger management tools for tracking and distributing vaccines, are helping control disease more effectively.
Joint research and government support are paving the way for further market development, making it impossible for veterinary vaccines to be overlooked in animal health and welfare.
Strategic Growth Opportunities for Veterinary Vaccine Market
Various strategic growth opportunities can be identified in the veterinary vaccine market, supported by technological developments, rising consumer awareness levels, and changing regulatory frameworks. Key growth opportunities include the development of novel vaccine formulations, expanding market outreach, managing supply chain issues, undertaking research and development in partnerships, and adopting modern technologies for vaccine management. These opportunities help companies strengthen their market positions and meet the increasing demand.
• Developing Innovative Vaccine Formulations: Developing innovative vaccine formulations is a key growth strategy in the field of veterinary vaccines. Recent advances in immunology and biochemistry are pushing the limits for manufacturers to develop and produce more efficient and safer vaccines. Specifically, companies will be able to create animal-specific vaccines, making them much more effective against specific diseases and enhancing the health of animals. This innovation will increase the demand for veterinary vaccines, benefiting both animals and the veterinary sector.
• Expanding into New Geographies: Expanding into new geographies is a key growth activity for veterinary vaccine manufacturers. As economies develop and campaigns to promote animal health increase, the demand for vaccines is on the rise. Organizations that focus on building and expanding operations in regions such as the Asia-Pacific and Latin America will benefit from new clientele and growth. Product modifications and targeted advertising will be essential to achieving success in these areas.
• Improving Supply Chain Management: Improving supply chain management is crucial for increasing vaccine availability and lowering costs in the veterinary vaccine market. Enhancing distribution structures and logistics makes it easier and faster to provide veterinarians and farms with the necessary doses of vaccines. Organizations that upgrade their supply chains will improve productivity and better respond to market demands. This improvement will lead to higher vaccination numbers and better management of livestock diseases.
• Vaccines for Wildlife: Vaccinating wildlife populations is gradually becoming necessary to control the spread of diseases that would otherwise affect both wildlife and domestic animals. As human encroachment into wildlife habitats increases, the chances of consuming food contaminated with diseases like zoonotic diseases rise. Rabies control in wildlife using oral rabies vaccines is a critical step for resource protection and public health. This application enables wildlife agencies to collaborate with veterinarians to promote the development and use of vaccines in broader ecosystems.
• Vaccines for Zoonotic Disease: Due to zoonotic diseases, there is a growing interest in developing vaccines that cater to both animals and humans. Veterinary vaccines are gaining momentum in targeting diseases such as the West Nile virus. The growing resolution of pressing public health issues like zoonotic disease transmission has fostered cooperation between veterinary and public health professionals. This trend focuses not only on improving animal health but also on preventing the outbreaks of disease pandemics.
The growth of the veterinary vaccine market is approaching a critical threshold due to strategic opportunities within the veterinary applications for companion animals, livestock, aquaculture, wildlife, and zoonotic disease vaccines. As these areas evolve, the market is expected to see more innovations, improved health, and more inter-industry collaborations.
Veterinary Vaccine Market Driver and Challenges
When it comes to the veterinary vaccine market, several drivers and constraints of technological, economic, or legal nature come into play. It is important for stakeholders to understand these drivers as well as the challenges they are likely to encounter in the course of engaging in such activities, as the outlook may not be clear and straightforward. Below are two key drivers related to the market and how each of them presents risks to its growth opportunities.
The factors driving the veterinary vaccine market include:
• Increasing Pet Ownership: The global increase in pet ownership is perhaps the most important factor contributing to the growth of the veterinary vaccine market. As more households bring pets into their homes, there is growing concern about the health of pets and the need for vaccination. Pet owners are increasingly seeking veterinary services, which has led to a higher demand for pet vaccination. This trend encourages veterinary practices to adopt new vaccines and technologies, creating more opportunities in the market.
• Advancements in Vaccine Technology: In the last few decades, there have been significant advances in modern biotechnology that have greatly impacted vaccine strategies in veterinary science, such as genetic engineering and mRNA vaccines. These advancements facilitate the formulation of effective and less reactogenic vaccines. Additionally, the relative ease of new routes of administration, such as oral vaccines or nasal sprays, further enhances the appeal of vaccines to veterinarians and pet owners as they are less invasive. This development is essential for addressing changing health challenges.
• Regulatory Support and Standards: Policies and regulations aimed at promoting the development and licensing of vaccines are major factors influencing the veterinary vaccine market. Governments and organizations recognize the role of vaccination in preventing diseases that could threaten livestock and the food supply. Improved regulatory frameworks and faster approval procedures are supporting vaccine development, including vaccines with more active pharmaceutical ingredients than those currently used. This environment creates opportunities to introduce new vaccines and fosters innovation, thereby increasing public confidence in the veterinary profession.
• Globalization of Animal Trade: The globalization of animal trade presents both opportunities and challenges for the veterinary vaccine market. With more animals being transported illegally or emotionally, there are greater risks of spreading infectious diseases. This creates a need for effective vaccination strategies to protect these populations. Additionally, disease prevention requirements lead to trade regulations that encourage vaccination, thus increasing productivity. However, it also means that substantial resources and efforts for monitoring and compliance with public health safety are necessary.
• Focus on Food Safety and Security: The focus on food safety and security has increased the demand for livestock vaccination. With growing awareness among consumers about the risks of foodborne diseases, farm owners are under pressure to vaccinate animals to ensure healthy animals and safe food systems. Vaccines that prevent diseases in poultry, livestock, and aquaculture are becoming key elements of the agricultural industry, enhancing market growth and food security.
Challenges in the veterinary vaccine market include:
• High Costs of Vaccine Development: Few challenges are more significant than addressing the economic factors associated with the research, development, and marketing of new veterinary vaccines. R&D involves high costs for technology development, clinical trials, and regulatory requirements. These costs may discourage smaller players from entering the industry, thus limiting competition and growth. Additionally, the rising costs may lead to higher fees for animal healthcare, limiting access for some owners.
• Limited Awareness and Education: The lack of awareness and the need for education on vaccination issues among pet owners and livestock producers hinder market growth. Some pet owners may be reluctant to vaccinate their animals due to myths about the safety and effectiveness of vaccines. Educating owners about the benefits of vaccination is essential to address these misconceptions and improve adherence to vaccination programs.
• Regulatory Hurdles and Compliance: Regulatory complexities can present challenges to vaccine developers and manufacturers. If obtaining approval is too difficult or if there are differing regulations in each region, it can delay the release of new vaccines. Compliance with protocols can also increase overhead costs. These barriers could stifle vaccine innovation and slow progress in the market and in improving overall animal health.
The veterinary vaccine market is influenced by several determining factors and barriers, including pet ownership, technological improvements, regulatory support, globalization, and food safety. However, challenges such as high development costs, limited awareness, and regulatory hurdles could slow down progress. Addressing these issues while capitalizing on the identified drivers is essential for achieving growth and improvement in the animal health sector.
List of Veterinary Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies veterinary vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veterinary vaccine companies profiled in this report include-
• Zoetis
• Merck
• Boehringer Ingelheim International
• Elanco Animal Health
• Virbac
Veterinary Vaccine by Segment
The study includes a forecast for the global veterinary vaccine by product, animal type, distribution channel, and region.
Veterinary Vaccine Market by Product [Analysis by Value from 2018 to 2030]:
• Inactivated
• Live Attenuated
• Recombinant
• Others
Veterinary Vaccine Market by Animal Type [Analysis by Value from 2018 to 2030]:
• Companion
• Livestock
Veterinary Vaccine Market by Distribution Channel [Analysis by Value from 2018 to 2030]:
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others
Veterinary Vaccine Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Veterinary Vaccine Market
The veterinary vaccine market is expected to see significant growth due to factors such as an increasing pet population, rising awareness about animal health, and the growing threat of zoonotic diseases. Advances in vaccine technologies are improving the safety and effectiveness of vaccines. Notably, all countries leading the veterinary vaccine market, such as the United States, China, Germany, India, and Japan, are developing unique strategies that will shape the future of veterinary vaccines.
• US: The American veterinary vaccine market is experiencing steady growth, particularly due to the rapid integration of new technologies, especially mRNA vaccines. mRNA vaccines for pets are under development by firms aiming to boost immune responses while minimizing side effects. Increased R&D spending is leading to the development of combination vaccines with broader coverage. The pace of regulatory approvals is also improving, which will support the adoption of specialized vaccines for pets and livestock.
• China: The veterinary vaccine market in China is growing gradually, driven by the government’s increasing focus on animal health. Domestic manufacturers are entering into joint ventures with global players to enhance their production capabilities and develop better quality vaccines for the Chinese market. There is significant research on diseases such as African Swine Fever and avian influenza, enabling the creation of effective vaccines tailored to local needs, which is contributing to the overall market expansion.
• Germany: Germany’s veterinary vaccine market is characterized by a dynamic and efficient legal and business environment. This trend is pushing the country toward commercializing vaccines for emerging diseases, such as Lyme disease in animals and infectious diseases in cattle. The use of recombinant DNA in vaccine production is becoming standard practice, improving vaccine efficacy. Additionally, the focus on enhancing vaccination is driving growth in the vaccine market, transforming the veterinary healthcare system.
• India: India is experiencing rapid growth in the veterinary vaccine market due to increasing awareness about animal health and rising livestock numbers. New initiatives, such as government vaccination drives, aim to control diseases and enhance productivity. Both local industries and international firms are introducing strategies to make vaccines affordable and accessible to farmers. Improved access to distribution networks is also making vaccines more available in rural regions.
• Japan: Japan’s agricultural biotechnology sector is driving growth in pet vaccination manufacturing. Recent developments, such as advanced vaccines for leptospirosis and feline leukemia in companion animals, are contributing to this trend. Additionally, policies like fast-track approval for vaccines have improved the market dynamics by reducing the time needed to introduce new products. The growing trend of pet humanization is also increasing the demand for vaccines tailored to the specific needs of pet owners.
Features of the Global Veterinary Vaccine Market
Market Size Estimates: Veterinary vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Veterinary vaccine market size by product, animal type, distribution channel, and region in terms of value ($B).
Regional Analysis: Veterinary vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, animal types, distribution channels, and regions for the veterinary vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veterinary vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What is the veterinary vaccine market size?
Answer: The global veterinary vaccine market is expected to reach an estimated $14.3 billion by 2030.
Q2. What is the growth forecast for veterinary vaccine market?
Answer: The global veterinary vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the veterinary vaccine market?
Answer: The major drivers for this market are increasing number of zoonotic illnesses, growing customer demand for foods derived from animals, and rising initiatives from numerous governmental organizations and animal associations.
Q4. What are the major segments for veterinary vaccine market?
Answer: The future of the veterinary vaccine market looks promising with opportunities in the veterinary hospital, veterinary clinic, and pharmacy & drug store markets.
Q5. Who are the key veterinary vaccine market companies?
Answer: Some of the key veterinary vaccine companies are as follows:
• Zoetis
• Merck
• Boehringer Ingelheim International
• Elanco Animal Health
• Virbac
Q6. Which veterinary vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that live attenuated is expected to witness the highest growth over the forecast period.
Q7. In veterinary vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the veterinary vaccine market by product (inactivated, live attenuated, recombinant, and others), animal type (companion and livestock), distribution channel (veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Veterinary Vaccine Market, Veterinary Vaccine Market Size, Veterinary Vaccine Market Growth, Veterinary Vaccine Market Analysis, Veterinary Vaccine Market Report, Veterinary Vaccine Market Share, Veterinary Vaccine Market Trends, Veterinary Vaccine Market Forecast, Veterinary Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.